anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

212,161-212,220 of 319,975

filter-aware
09
Includes a disclaimer about rounding differences.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
10
Includes a footnote regarding the definition of Adjusted EBITDA and rounding.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
The slide presents two distinct tables: one for percentage ratios and one for YoY basis point changes.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Pareto Focus1 hit
12
The slide uses lettered callouts (A-F) to map specific adjustments to their definitions on the right.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations 1 hit
13
Includes a table of medical centers by state and a summary table of key metrics (states, centers, members) over time.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations 1 hit
01
Slide 1
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
02
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
03
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style chart to represent drug development progress.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
05
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
06
Includes a Kaplan-Meier survival curve, an anatomical illustration of tumor locations, and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
BICR = Blinded Independent Central Review; RANO = Response Assessment in Neuro-Oncology; HGG = High-Grade Glioma; LGG = Low-Grade Glioma; SAEs = Serious Adverse Events.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
08
The slide details specific inclusion/exclusion criteria, including age, mutation status, prior therapy, and washout periods.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
09
The slide highlights clinical trial results with specific response and disease control rates for two different RANO criteria.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
10
The chart is a waterfall plot (often called a swimmer plot or spider plot in oncology, though technically a waterfall).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
11
The chart is a waterfall plot showing Best % Change in SPD from Baseline. The legend indicates PS scores (060-100).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
12
The chart is a classic 'spider plot' used in oncology clinical trials to visualize individual patient tumor burden changes over time.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
13
Data presented in two tables comparing healthy adult dose escalation vs glioma patient safety profiles.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide highlights the correlation between RANO response criteria and improved clinical outcomes in H3 K27M-mutant DMG patients.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The table uses a color-coded heatmap to highlight favorable (green) vs unfavorable (pink) characteristics of clinical trial data.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
16
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
17
The slide uses a process flow diagram to illustrate the trial structure.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
18
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
19
The slide details specific event counts and target hazard ratios for OS and PFS endpoints.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
20
The chart shows a dose-response curve where longer incubation times (48+ hours) result in higher efficacy (lower cell viability) at lower concentrations compared to 24 hours.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
21
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
22
The slide uses a medical illustration of the brain to map patient counts and positivity rates to specific anatomical regions.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
23
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
24
Slide 24 of the deck.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
25
Waterfall plot displays individual patient responses; PD indicates Progressive Disease threshold.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
26
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
27
Includes a detailed biological pathway diagram showing mitochondrial and membrane-level interactions.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
28
Includes citations to Chi et al. (2017) and Piccardo et al. (2019).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
29
Includes a mechanism illustration, a bar chart of H3K27me3 levels, a Kaplan-Meier survival curve, and a dot plot of patient tumor data.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
30
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
31
Includes molecular structure and protein target visualizations.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
32
The slide uses a central human anatomical illustration to bridge the two distinct types of cancer models presented.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
33
Includes logos for NIH and Pacific Pediatric Neuro-Oncology Consortium.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
34
Includes an in vitro cell viability dose-response curve and a pharmacokinetic (PK) model showing plasma concentration over time.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
35
The chart illustrates dose levels 1-11 with checkmarks indicating completed levels and a clear distinction between weekly and 3-day dosing regimens.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
36
Uses a visual icon array to represent survival rates.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
37
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
38
The slide uses a visual comparison of tumor burden in mice to demonstrate efficacy.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
39
The chart shows a clear dose-response/timing-response relationship where earlier treatment leads to lower viral titers.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
40
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
41
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
42
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
43
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
01
Slide 1
Cipher Mining | Investor Presentation Deck | 17 slidesCipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
02
Cipher Mining | Investor Presentation Deck | 17 slidesCipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
03
The slide highlights cost efficiency, energy stability, and expansion progress ahead of the Bitcoin halving event.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
04
The slide uses a grid layout to present operational KPIs.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
05
Uses a value-chain style flow to explain the mining process.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
06
The slide uses a timeline-annotated line chart to correlate market events with price volatility.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
07
The slide uses a split layout: left side for operational cost metrics and right side for growth trajectory.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
08
The slide features a photo of the Odessa facility and a timeline of hash rate growth.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
09
Includes aerial photography of the facility.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
10
Includes aerial photography of the mining facility.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
11
Cipher Mining | Investor Presentation Deck | 17 slidesCipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
12
Financial statement data presented in thousands.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit